SALIX PHARMACEUTICALS LTD Sales Returns and Allowances, Goods (Deprecated 2018-01-31)
SALIX PHARMACEUTICALS LTD reported Sales Returns and Allowances, Goods (Deprecated 2018-01-31) of $34.80 million for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-08.
Discontinued › Notes
us-gaap:SalesReturnsAndAllowancesGoods · last filed 2012-11-08
- SALIX PHARMACEUTICALS LTD sales returns and allowances, goods (deprecated 2018-01-31) for the quarter ending 2012-09-30 was $200.00K, a 93.33% decline year-over-year.
- SALIX PHARMACEUTICALS LTD sales returns and allowances, goods (deprecated 2018-01-31) for the quarter ending 2012-06-30 was $2.60M.
- SALIX PHARMACEUTICALS LTD sales returns and allowances, goods (deprecated 2018-01-31) for the quarter ending 2012-03-31 was $32.00M.
- SALIX PHARMACEUTICALS LTD sales returns and allowances, goods (deprecated 2018-01-31) for the quarter ending 2011-12-31 was $2.60M.
- SALIX PHARMACEUTICALS LTD sales returns and allowances, goods (deprecated 2018-01-31) for fiscal 2010 was $18.20M.
| Period end | Sales Returns and Allowances, Goods (Deprecated 2018-01-31) 3 month | Sales Returns and Allowances, Goods (Deprecated 2018-01-31) 6 month | Sales Returns and Allowances, Goods (Deprecated 2018-01-31) 9 month | Sales Returns and Allowances, Goods (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2012-09-30 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $2.80M derived: sum of 2 quarters · filed 2012-11-08 | $34.80M 10-Q · filed 2012-11-08 | $37.40M derived: sum of 4 quarters · filed 2012-11-08 |
| 2012-06-30 | $2.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $34.60M 10-Q · filed 2012-08-09 | $37.20M derived: sum of 3 quarters · filed 2012-11-08 | $40.20M derived: sum of 4 quarters · filed 2012-11-08 |
| 2012-03-31 | $32.00M 10-Q · filed 2012-05-08 | $34.60M derived: sum of 2 quarters · filed 2012-11-08 | $37.60M derived: sum of 3 quarters · filed 2012-11-08 | |
| 2011-12-31 | $2.60M derived: 10-Q 12 month − 10-Q 9 month · filed 2012-11-08 | $5.60M derived: sum of 2 quarters · filed 2012-11-08 | $27.90M 10-Q · filed 2012-11-08 | |
| 2011-09-30 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $25.30M 10-Q · filed 2011-11-09 | ||
| 2011-06-30 | $22.30M 10-Q · filed 2011-08-09 | |||
| 2010-12-31 | $18.20M 10-K · filed 2012-02-28 |